Answer
Yes, breastfeeding should be discontinued during treatment with Votrient (pazopanib hydrochloride), because safe use during breastfeeding has not been established and a risk to the breastfed child cannot be excluded.
Sources for this answer
- Votrient 200 mg and 400 mg film coated tabletsNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 36Document updated
Sources checked